Mitochondrial Pharmacology of Dimebon (Latrepirdine) Calls for a New Look at its Possible Therapeutic Potential in Alzheimer’s Disease

Dimebon (latrepirdine), an old antihistaminic drug, showed divergent results in two large clinical trials in Alzheimer disease (AD), which according to our review might be related to the specific pharmacological properties of the drug and the different patient populations included in both studies. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Eckert, Schamim H, Gaca, Janett, Kolesova, Nathalie, Friedland, Kristina, Eckert, Gunter P, Muller, Walter E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065284/
https://www.ncbi.nlm.nih.gov/pubmed/30090660
http://dx.doi.org/10.14336/AD.2017.1014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065284/
https://www.ncbi.nlm.nih.gov/pubmed/30090660
http://dx.doi.org/10.14336/AD.2017.1014

Ejemplares similares